Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
US Department of Veterans Affairs
This is a randomized-control clinical trial. After completion the baseline assessment, subjects will be randomly assigned to either standard pharmacotherapy or SP+CBSST and will be followed for 18 months. The subjects will be 180 outpatients over the age of 45 with a diagnosis of schizophrenia or schizoaffective disorder.
Age
45–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must be 45 years of age or older with a diagnosis of schizophrenia or schizoaffective disorder.
